Hims & Hers Health (HIMS)
NYSEHealth CareMedical - Care FacilitiesSnapshot 2026-09-09
$27.90-0.96%
Close 2026-09-09 · 1-day change
NYSEHealth CareMedical - Care FacilitiesSnapshot 2026-09-09
Broken: Recent financial performance freshly dropped to the bottom half of its industry.
Hims & Hers aims for $2.8-$3.0 billion revenue in 2026. Subscribers grew 9% to 2.6 million in Q1. The company raised full-year revenue guidance. Cash flow and profit are still weak but improving.
The company lost $0.40 per share in Q1 2026. Operating income fell to negative $78.3 million. Cash from operations declined year over year. Growth may slow and losses may continue.
The price is about 35% above our fair value near $27. Analysts expect 53% revenue growth. Our view aligns with Street estimates but sees risk in profit and cash flow.
Breaks if: Cash from operations falls below $89 million quarterly
Breaks if: Operating income remains below negative $78 million
Revenue falls below $2.8 billion in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This is a speculative growth investment with a focus on long-term revenue expansion. The current thesis state has weakened due to recent financial performance issues and management volatility.
The market seems to price in a cheap valuation compared to peers, but there is an expectations gap indicating that investors anticipate some challenges ahead. The current valuation suggests that the market is not overly optimistic about HIMS's near-term prospects.
Fundamentals may struggle in the near term due to a high probability of missing earnings expectations and recent weak financial performance. Management's focus on revenue growth and international expansion shows promise, but execution remains mixed.
The long-term thesis hinges on management's ability to deliver on revenue growth targets and successfully expand internationally. Additionally, the performance of sector bellwethers and overall economic conditions will be crucial in determining HIMS's trajectory.
The most important moves since the prior daily snapshot.
Yes, our read has weakened. Hims & Hers will incur an $8 surcharge on each credit card dispute. This will lead to higher costs and ongoing financial penalties if dispute rates remain elevated. Additionally, recent financial performance dropped from the top half to the bottom half of its industry.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: Subscriber count falls below 2.6 million
Over the next 1 to 3 years, HIMS's path will depend on effective management execution and external market conditions. Not investment advice.